Results 41 to 50 of about 10,542 (115)

Not just splitting hairs—monitoring environmental chemical exposures, their biological effects and their social determinants with hair shafts and follicles: a narrative review

Environmental Health
Humans encounter a wide range of natural and synthetic chemicals throughout their lifespan and these exposures have a complex impact on health outcomes.
Marie Robert, Alba Iglesias-González, Rawan Nour, Ke Zhou, Brice M.R. Appenzeller, Martine Bellanger, Pierre-Alexandre Vidi   +6 more
doaj   +1 more source

Patient‐ and caregiver‐reported barriers to radiotherapy for cancer in sub‐Saharan Africa—A survey of population‐based registries

International Journal of Cancer, Volume 159, Issue 3, Page 595-608, 1 August 2026.
What's New? Low‐ and middle‐income countries have over 70% of the global cancer burden but 10% of the world's radiotherapy capacities. This population‐based multi‐country study explores the barriers to access experienced by cancer patients in sub‐Saharan Africa.
Eric Sven Kroeber, Tamara König, Ole Stöter, Biying Liu, Phoebe Mary Amulen, Margaret Borok, Gladys Chesumbai, Eric Chokunonga, Ima‐Obong Ekanem, Mahine Ivanga, Bakarou Kamaté, William Muller, Abidemi Omonisi, Jean‐Félix Peko, Mathewos Assefa, Furaha Serventi, Markus Wallwiener, Mazvita Muchengeti, Pablo Sandro Carvalho Santos, Donald Maxwell Parkin, Eva Johanna Kantelhardt, Nikolaus Christian Simon Mezger   +21 more
wiley   +1 more source

Progression-Free Survival Under Immune Checkpoint Inhibitors for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Cohort Study

Oncology and Therapy
Introduction Immune checkpoint inhibitors (ICI) are the standard of care for non-small-cell lung cancer (NSCLC) regardless of program death ligand-1 (PDL1) expression.
Paul Boré, Margaux Geier, Loïc Campion, Jean-Luc Raoul, Ludovic Doucet, Sandrine Hiret, Frédéric Bigot, François Bocquet, Laura Mezquita, Teresa Gorria, Judith Raimbourg   +10 more
doaj   +1 more source

The theranostic: an innovative combination for the diagnosis and therapy of cancers

Journal de la Faculté de Médecine d'Oran, 2022
La recherche en cancérologie doit répondre à un double défi : le diagnostic précoce des tumeurs pour permettre une thérapie efficace et le développement de nouvelles thérapies ciblées. Dans la lutte contre le cancer, les recherches actuelles s’orientent
Nassima MOUSSAOUI
doaj  

Transcriptomic comparative study between canalicular adenoma and HMGA2::WIF1 canalicular‐like pleomorphic adenoma

The Journal of Pathology, Volume 269, Issue 4-5, Page 423-432, August 2026.
Abstract Canalicular adenoma (CA) is a benign salivary gland tumor predominantly affecting the upper lip and is characterized by monomorphic epithelial cells arranged in branching cords within a loose and vascularized stroma. Unlike pleomorphic adenoma (PA), CA lacks a chondroid matrix and exhibits specific histological features, such as high cuboidal ...
Ziyad Alsugair, Anne Champagnac, Maxime Fieux, Pierre Philouze, Philippe Ceruse, Brice Thamphya, Daniel Pissaloux, Franck Tirode, Nazim Benzerdjeb   +8 more
wiley   +1 more source

Anatomy-based correction of kidney PVE on $$^{177}\text{Lu}$$ 177 Lu SPECT images

EJNMMI Physics
Background In peptide receptor radionuclide therapy (PRRT), accurate quantification of kidney activity on post-treatment SPECT images paves the way for patient-specific treatment.
Julien Salvadori, Oreste Allegrini, Thomas Opsommer, Josefina Carullo, David Sarrut, Clemence Porot, Florian Ritzenthaler, Philippe Meyer, Izzie-Jacques Namer   +8 more
doaj   +1 more source

ctDNA Detection of Polyclonal KRAS Resistance in Adagrasib‐Treated NSCLC

Thoracic Cancer, Volume 17, Issue 15, August 2026.
Longitudinal ctDNA monitoring by ddPCR and targeted NGS in an adagrasib‐treated KRASG12C mutant NSCLC patient revealed the emergence of three new KRAS mutations (G12D, G13D, Q61H), indicating polyclonal resistance, approximately 10 weeks before any radiologic progression by RECIST 1.1.
Marion Caumeil, Julie A. Vendrell, Simon Cabello‐Aguilar, Sarah Cavaillon, Quentin Dominique Thomas, Jérôme Solassol   +5 more
wiley   +1 more source

Prognostic Impact of Concomitant Genomic Alterations in FGFR2‐Positive Cholangiocarcinoma Treated With Pemigatinib

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background & Aims Anti‐FGFR therapies changed the treatment landscape for patients with previously treated, advanced, or metastatic cholangiocarcinoma (CCA) harbouring FGFR2 fusions/rearrangements. However, primary resistance to FGFR inhibitors remains a key challenge. In the present real‐world study, we aimed to evaluate the prognostic impact
Carolina Liguori, Riccardo Giampieri, Blandine Delaunay, Giada Pinterpe, Adelaide Mazzocca, Antoine Hollebecque, Jean Frederic Blanc, Mohamed Bouattour, Eric Assenat, Meher Ben Abdelghani, Matthieu Sarabi, Monica Niger, Caterina Vivaldi, Mario Mandalà, Andrea Palloni, Maria Bensi, Silvio Ken Garattini, David Tougeron, Pierre Combe, Massimiliano Salati, Margherita Rimini, Andrea Casadei‐Gardini, Chiara Alessandra Cella, Marco Tucci, Anna Diana, Elena Mori, Raffaella Longarini, Pascal Artru, Gael Roth, Ludovic Evesque, Agathe Vienne, Anthony Turpin, Sandrine Hiret, Vincent Bourgeois, Camille Herve, Rodolphe Paulon, Marion Stacoffe, David Malka, Matthieu Delaye, Julien Edeline, Astrid Lievre, Rosine Guimbaud, Rita Balsano, Nadim Fares, Rossana Berardi, Alessandro Parisi   +45 more
wiley   +1 more source

Systemic anti‐cancer therapy associated with the occurrence of peripheral neurotoxicity and, specifically, peripheral neuropathy

International Journal of Cancer, Volume 159, Issue 2, Page 460-466, 15 July 2026.
What's new? While the effectiveness of systemic anticancer therapy is well documented, it commonly causes severe toxicity. This study of the 467 systemic anticancer therapy agents currently approved globally for clinical and/or research purposes found that peripheral neurotoxicity is associated with 45% of classical chemotherapies, 21% of targeted ...
Cassie Higgins, Lynn R. Gauthier, Blair H. Smith, Lesley Colvin   +3 more
wiley   +1 more source

The European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer: Methodological Protocol

Clinical and Public Health Guidelines, Volume 3, Issue 3, July 2026.
ABSTRACT Background Pancreatic cancer remains one of the most lethal cancers despite extensive efforts and research conducted over the past decades. To effectuate groundbreaking improvements in pancreatic cancer treatment, interdisciplinary and international collaboration is essential.
Laura C. Leeuwenburgh, Magdalena Holze, Dena Akhoundzadeh, Adnan Alsourani, Ricardo Alvarez Jimenez, Paul C. M. Andel, Charlotte Baggerman van Houweninge, Alberto Balduzzi, Caro L. Bruna, Fabio Casciani, Alice Cattelani, Aniek E. van Diepen, Heleen Driessens, Daphne H. M. Droogh, Jeska A. Fritzsche, Eline van Gansewinkel, Luana Genova, Anne M. Gehrels, Gonzalo Gómez Dueñas, Riccardo Guastella, Lis S. M. Hoeijmakers, Tijs J. Hoogteijling, Ammar A. Javed, Berk Kaan Aktas, Benedict Kinny‐Köster, Amber Lamoré, K. Seng Liem, Gabriella Lionetto, Lorenzo Lo Faro, Lisanne Lutter, Manuela Mastronardi, Carlo H. Maurer, Roberto Montorsi, Julian Musa, Ingmar F. Rompen, Jacobien C. M. Scheepens, Dana Sochorová, Thomas F. Stoop, Nuray Tezcan, Bas A. Uijterwijk, Roberta Vella, Federica Vernuccio, Rogier P. Voermans, Mohammad Abu Hilal, Volkan Adsay, Hana Algül, Valentina Ambrosini, Livia Archibugi, Eva Backman, Sorin T. Barbu, Ugo Boggi, Charlotte Borge‐Andersen, Stefan Kobbelgaard Burgdorf, Alice Clarkson, Eric van Cutsem, Pieter‐Jan Cuyle, Lois A. Daamen, Peter De Rosa, Marcel den Dulk, Celia Diez de los Rios, Amanda Drury, Irene Esposito, Simon M. Everett, Arantza Farina Sarasqueta, Isabella Frigerio, Bas Groot Koerkamp, Thilo Hackert, Florence Huguet, Nikolaos Kartalis, Anne Letsch, Pex Langenberg, Denny Levett, Gabor Liposits, Núria Malats, Hannah van Malenstein, Giuseppe Malleo, Zorana Maravic, Giovanni Marchegiani, Ana Martins, Martijn R. Meijerink, Christoph W. Michalski, J. Sven D. Mieog, Eleni Moka, Somnath Mukherjee, Cristina Nanni, Franco Orsi, Demetris Papamichael, Stefano Partelli, Cathy Payne, Ilaria Pergolini, Dejan Radenkovic, Keith J. Roberts, Roberto Salvia, Alain Sauvanet, Marta Scorsetti, Matthias Seebo, Thomas Seufferlein, Stefan Stättner, Geoffroy Vanbiervliet, Caroline S. Verbeke, Thomas Volk, Jens Werner, Johanna W. Wilmink, Marc Zins, Thierry Conroy, Per Pfeiffer, Michel Ducreux, Mahsoem Ali, Miranda Langendam, Yasaman Vali, Elena B. Rangelova, Marc G. Besselink, for the Multi‐Societal European Evidence‐Based Guideline on Pancreatic Cancer   +112 more
wiley   +1 more source